Mainstay Medical Limited: PMA supplement approved for ReActiv8 Implantable Neurostimulation System

Mainstay Medical Limited (Swords, Co Dublin): PMA supplement approved for ReActiv8 Implantable Neurostimulation System. Dated 16 days ago, it is in the active follow-up window. Score 60/100. As of 2026-11-04, from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration).

Data as of · Compiled by Zalwin from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)

Free preview: all 8 published fields of this record are shown below. Locked: 499 related FdaApprovalPulse records and the 4-column CSV export.

FieldValue
SponsorMainstay Medical Limited
ProductReActiv8 Implantable Neurostimulation System
Generic / ingredientStimulator, neuromuscular, lower back muscles, totally implanted for pain relief
ApprovalPMA supplement (device change)
ApplicationP190021 S012
Decided2026-10-19
Panel / classNeurology
Sponsor locationSwords, Co Dublin
Peer records CSV (500 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch Mainstay Medical Limited

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock Mainstay Medical + 500 peer records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Product · Approval · Decided · official source URL

  • Source agency: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)
  • Record date: 2026-10-19
  • Data refreshed: 2026-11-04
  • Refunds on request within 14 days

Search all records free →

Top FdaApprovalPulse records: Instylla, Inc. · Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) · Cerenovus, Inc. · Advanced Medical Solutions Limited · Lenstec, Inc. · Browse all by state and category →

LIVE PUBLIC DATA Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration) · Last refreshed: Wed, 04 Nov 2026 06:06:18 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Search, filter and export more FdaApprovalPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

60 / 100 Score

  • Decided in the last 30 days.

What is the FdaApprovalPulse record for Mainstay Medical Limited in Swords, Co Dublin?

The FDA approved ReActiv8 Implantable Neurostimulation System (P190021 S012) for Mainstay Medical Limited on 2026-10-19: PMA supplement (device change).

How does Mainstay Medical Limited compare to other FdaApprovalPulse records?

It is 16 days old, still within a typical 45-day follow-up window.

Mainstay Medical Limited vs. top 3 peers

OrganizationLocationRecord date
Mainstay Medical LimitedSwords, Co Dublin2026-10-19
Instylla, Inc.Bedford, MA2026-10-23
Ventana Medical Systems, Inc. (Roche Tissue Diagnostics)Tucson, AZ2026-10-23
Cerenovus, Inc.Miami, FL2026-10-23

Related records

FdaApprovalPulse: PMA supplement (device change)

How to monitor Mainstay Medical Limited and peer pma supplement (device change) records

Get new FdaApprovalPulse records like Mainstay Medical Limited by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new approvals in your categories

FdaApprovalPulse emails new device and drug approvals matching your approval types.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

From openFDA (PMA and Drugs@FDA). openFDA can lag FDA decisions by days to weeks. Drug supplement types follow the FDA submission class (labeling and REMS, manufacturing/CMC, efficacy, other). Company and product level only. Verify on FDA databases before relying on an approval.

Often used together